Objective To evaluate outcomes with mifepristone 200 mg orally followed 24–48 h later by
misoprostol 800 mcg vaginally for medical abortion at 64–70 days of gestation. Study design …

BACKGROUND: The dose of mifepristone approved by most government agencies for
medical abortion is 600 mg. Our aim was to summarize extant data on the effectiveness and …

Objective To compare the efficacy, adverse effects and acceptability of the three most
common misoprostol regimens used with mifepristone for medical abortion. Design …

Please cite this paper as: von Hertzen H, Huong N, Piaggio G, Bayalag M, Cabezas E, Fang
A, Gemzell‐Danielsson K, Hinh N, Mittal S, Ng E, Chaturachinda K, Pinter B, Puscasiu L …

HYPOTHESIS: Simultaneous administration of mifepristone and misoprostol for medical
abortion in women up to 49 days gestation will result in complete abortion in 90% of women …

Objectives To compare the efficacy of two different regimens of mifepristone followed by
misoprostol for medical abortion in women with menstrual delay of≤ 35 days. Design …

Objective The aim of this study was to report on the safety and efficacy of an evidence-based
medical abortion regimen utilizing 200 mg of mifepristone orally followed by home use of …

The aim of this study was to compare the effectiveness, side effects, and acceptability of one-
third the standard dose of mifepristone, ie, 200 mg, and vaginal misoprostol 800 μg to …

OBJECTIVE: Mifepristone and oral misoprostol are typically used for medical abortion in
women up to 49 days of gestation, with a 36-to 48-hour interval between the medications …

This study assessed the efficacy and side effects of first trimester medical abortion using
mifepristone and vaginally administered misoprostol. Medical abortion was first introduced …